DEFINED DAILY DOSES IN RELATION TO HYPOLIPEMIC EFFICACY OF LOVASTATIN, PRAVASTATIN, AND SIMVASTATIN

被引：82

作者：

ILLINGWORTH, DR

ERKELENS, DW

KELLER, U

THOMPSON, GR

TIKKANEN, MJ

机构：

[1] UNIV UTRECHT HOSP, DEPT ENDOCRINOL, UTRECHT, NETHERLANDS

[2] KANTONSSPITAL, DEPT INTERNAL MED, CH-4031 BASEL, SWITZERLAND

[3] HAMMERSMITH HOSP, MRC, LIPOPROT TEAM, LONDON W12 0HS, ENGLAND

[4] UNIV HELSINKI HOSP, DEPT INTERNAL MED, HELSINKI, FINLAND

来源：

LANCET | 1994年 / 343卷 / 8912期

关键词：

D O I：

10.1016/S0140-6736(94)92945-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1554 / 1555

页数：2

共 17 条

[1] TREATMENT OF FAMILIAL HYPERCHOLESTEROLEMIA - UNITED-KINGDOM LIPID CLINICS STUDY OF PRAVASTATIN AND CHOLESTYRAMINE [J].

BETTERIDGE, DJ ;

BHATNAGER, D ;

BING, RF ;

DURRINGTON, PN ;

EVANS, GR ;

FLAX, H ;

JAY, RH ;

LEWISBARNED, NL ;

MANN, J ;

MATTHEWS, DR ;

MILLER, JP ;

RECKLESS, JPD ;

STURLEY, R ;

TAYLOR, KG ;

WINDER, AF .

BRITISH MEDICAL JOURNAL, 1992, 304 (6838) :1335-1338

[2] EXPANDED CLINICAL-EVALUATION OF LOVASTATIN (EXCEL) STUDY RESULTS .1. EFFICACY IN MODIFYING PLASMA-LIPOPROTEINS AND ADVERSE EVENT PROFILE IN 8245 PATIENTS WITH MODERATE HYPERCHOLESTEROLEMIA [J].

BRADFORD, RH ;

SHEAR, CL ;

CHREMOS, AN ;

DUJOVNE, C ;

DOWNTON, M ;

FRANKLIN, FA ;

GOULD, AL ;

HESNEY, M ;

HIGGINS, J ;

HURLEY, DP ;

LANGENDORFER, A ;

NASH, DT ;

POOL, JL ;

SCHNAPER, H .

ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (01) :43-49

[3] COMPARATIVE-STUDY OF THE EFFICACY AND TOLERABILITY OF SIMVASTATIN AND PRAVASTATIN IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA [J].

DOUSTEBLAZY, P ;

RIBEIRO, VG ;

SEED, M ;

BERTHEZENE, F ;

DEVULDER, B ;

FARNIER, M ;

GANCEL, A ;

GAUTIER, D ;

DEGENNES, JL ;

HESPEL, JP ;

LATAPIE, JL ;

REMY, JM ;

ROGER, P ;

TATER, D ;

THOMAS, M ;

AVILA, J ;

SILVA, PSE ;

GONCALVES, FR ;

VANHAFE, P ;

SIMOES, L ;

HUGHES, E ;

RYLANCE, P ;

WRAY, R ;

WILKINSON, P .

DRUG INVESTIGATION, 1993, 6 (06) :353-361

[4]

FARMER JA, 1992, CLIN THER, V14, P708

[5]

FROHLICH J, 1993, CAN J CARDIOL, V9, P405

[6] LOVASTATIN (MEVINOLIN) IN THE TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA - A MULTICENTER STUDY [J].

HAVEL, RJ ;

HUNNINGHAKE, DB ;

ILLINGWORTH, DR ;

LEES, RS ;

STEIN, EA ;

TOBERT, JA ;

BACON, SR ;

BOLOGNESE, JA ;

FROST, PH ;

LAMKIN, GE ;

LEES, AM ;

LEON, AS ;

GARDNER, K ;

JOHNSON, G ;

MELLIES, MJ ;

RHYMER, PA ;

TUN, P .

ANNALS OF INTERNAL MEDICINE, 1987, 107 (05) :609-615

[7] COMPARATIVE HYPOLIPIDEMIC EFFECTS OF LOVASTATIN AND SIMVASTATIN IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA [J].

ILLINGWORTH, DR ;

BACON, S ;

PAPPU, AS ;

SEXTON, GJ .

ATHEROSCLEROSIS, 1992, 96 (01) :53-64

[8] HYPOCHOLESTEROLEMIC EFFECTS OF MEVINOLIN IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA [J].

ILLINGWORTH, DR ;

SEXTON, GJ .

JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (06) :1972-1978

[9]

LAMBRECHT LJ, 1993, ACTA CARDIOL, V48, P541

[10]

MCPHERSON R, 1992, CLIN THER, V14, P276

← 1 2 →